DxC 500 AU Clinical Chemistry Analyzer
Recall Z-1233-2025, part of FDA recall event 96193. See Beckman Coulter Laboratory Systems (Suzhou)'s company page.
BECKMAN COULTER LABORATORY SYSTEMS (SUZHOU) CO., LTD. started this Class II device recall on Jan 10, 2025 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Jan 10, 2025
- Status: Ongoing
Beckman Coulter has identified an issue which prevents the DxC 500 AU instrument from providing the correct onboard stability (Open Expiration) dates for assays that were loaded prior to a software upgrade (e.g. 1.3 to 1.4, 1.4 to 1.4.1, etc.). As a result, assays that have expired may still be used for sample processing, leading to inaccurate or erroneous patient test results. The issue only happens on assays loaded before instruments doing upgrades and does not impact new installation. It does not impact the assays loaded after upgrade.
- Product
- DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software.
- Quantity
- 56
- Lots and codes
- Software Versions: V1.4, V1.4.1, V1.4.2, V1.4.3 REF/UDI-DI/Serial Numbers: C63519/14987666545058/2024090170; C63520/14987666545065/2024070116, 2023070009, 2024010038, 2024010035, 2024050072, 2024040056, 2024030049, 2024020046, 2024070111, 2024030051, 2024030052, 2024010033, 2023090015, 2024060103, 2024060104, 2024060101, 2024080145, 2024020045, 2024020042, 2024020043, 2024020047, 2024060096, 2024040059, 2023100019, 2024030053, 2023070010, 2024070129, 2024070130, 2024020041, 2024090183, 2024010036, 2024010037, 2024070132, 2024070131, 2023100020, 2024050064, 2024050070, 2023090016, 2023110022,…
- Distribution
- US: MA, CA, SC, LA, OK, GA, AL, TX, OR, ID, CO, MN, NY, MS, PA, WA, IL, MI, PR. OUS: Lebanon, Poland, Ghana, Spain, South Africa, Slovakia, Ghana, Croatia, Seychelles, Australia, Republic of Korea
- Recalling firm
- BECKMAN COULTER LABORATORY SYSTEMS (SUZHOU) CO., LTD., Suzhou, N/A, China
- How the firm notified
- Letter
- FDA classified
- Feb 25, 2025
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports